Editorial
Lu DY, Lu TR, Chen XL, Chen EH
Abstract
Last 20 years, this world has witnessed the rapid progresses of bioinformatics. Cancer bioinformatics is one of such important omics branches for drug developments and clinical applications. Same as other biological techniques or systems, bioinformatics are not omni-potent now. They have their own limits and shortcomings. This article addresses the panorama of bioinformatics in cancer researches and clinical applications. Their advantageous and drawbacks are discussed and highlighted.